Skip to main content

Featured

13 building plans approved in Nov

The Buildings Department approved 13 building plans in November - two on Hong Kong Island, six in Kowloon and five in the New Territories.   Of the approved plans, eight were for apartment and apartment-commercial developments, two for commercial developments, one for factory and industrial developments, and two for community services developments.   Consent was given for works to start on 11 building projects which will provide 210,471 sq m of gross floor area for domestic use involving 2,595 units and 83,060 sq m for non-domestic use.   Additionally, the department received notification of commencement of superstructure works for nine building projects.   The department also issued 16 occupation permits - three on Hong Kong Island, five in Kowloon and eight in the New Territories.   Buildings certified for occupation have 53,034 sq m of gross floor area for domestic use involving 1,355 units and 168,627 sq m for non-domestic use. http://dlvr.it/Sh3Dtw

Vaccine protection under scrutiny

Secretary for Food & Health Prof Sophia Chan said experts of the Joint Scientific Committee under the Centre for Health Protection will monitor the situation of new COVID-19 variants and review the data on the protection of various vaccines against such variants.   Speaking to the media after attending a radio programme today, Prof Chan noted that the committee has given information about the protection of different vaccines against the new variants.   She said: “According to the experts, the BioNtech vaccine is able to protect against some of the variants of concern. For the Sinovac vaccine, they are still waiting for further information from Sinovac.   “The experts will continue to monitor the situation and review any data provided to the Department of Health.”   For the vaccine produced by AstraZeneca, which the Government has signed an advance purchase agreement with, Prof Chan said the Government is aware of the news reports concerning the vaccine in different countries.   “We also notice there is news from the World Health Organization and also some countries most recently said that all the adverse effects are not related to or do not have a direct relationship with the vaccination of the AstraZeneca vaccine.   “We will continue to monitor the situation and the Department of Health has asked the manufacturer for further information.”   She explained that regarding the procedure, the manufacturer must first apply for approval for use in Hong Kong and the Advisory Panel on COVID-19 Vaccines will review the data before it recommends it for authorisation by the Government.   Such a process has not yet started, Prof Chan added.
http://dlvr.it/Rw1Gcv

Popular Posts